JP-listed companies
KNC Laboratories Co., Ltd.

KNC Laboratories Co., Ltd.JP:6568

Market cap

¥9B

P/E ratio

6.1x

Income statement Balance sheet Cash flow

	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024
Cash and deposits	1,263	5,413	3,072	1,476	1,963	1,974	2,297	3,312
Accounts receivable - trade	834	686	505	1,527	1,142	2,518	2,791	2,626
Finished goods	124	250	246	169	354	368	446	364
Work in process	685	589	609	820	1,039	922	1,134	1,411
Raw materials and supplies	133	136	242	296	350	482	700	743
Prepaid expenses	22	22	24	29	39	33	47	60
Other	49	27	77	17	250	50	45	43
Current assets	3,185	7,247	4,775	4,335	5,137	6,347	7,459	8,559
Buildings, net	2,395	2,297	2,853	3,092	3,160	3,211	3,622	3,576
Structures, net	80	59	63	80	80	103	124	138
Machinery and equipment, net	1,510	1,412	1,547	1,567	1,623	1,401	1,433	1,410
Vehicles, net	10	11	8	6	5	4	11	6
Tools, furniture and fixtures, net	74	92	123	166	162	129	155	152
Land	1,238	1,238	1,822	1,822	1,822	1,842	1,847	1,847
Construction in progress	33	26	212	962	109	218	9	1,346
Property, plant and equipment	5,340	5,135	6,628	7,696	6,961	6,909	7,200	8,475
Software	24	17	68	76	56	43	39	29
Other	2	2	3	3	3	2	24	24
Intangible assets	39	29	79	84	61	46	64	53
Investment securities	135	189	265	314	265	238	221	344
Investments in capital	15	24	28	22	16	16	11	-
Deferred tax assets	-	-	70	167	200	269	337	1,152
Other	118	143	157	152	141	127	113	39
Investments and other assets	274	400	521	656	622	650	682	1,535
Non-current assets	5,654	5,564	7,228	8,435	7,644	7,604	7,945	10,063
Assets	8,839	12,769	12,002	12,771	12,781	13,952	15,405	18,622
Accounts payable - trade	430	410	257	233	256	278	306	300
Short-term borrowings	300	-	-	-	-	200	500	-
Current portion of long-term borrowings	680	1,279	778	460	360	440	440	658
Accounts payable - other	307	209	538	480	158	285	311	145
Accrued expenses	70	121	107	102	107	107	131	144
Income taxes payable	12	407	202	122	136	237	565	1,169
Accrued consumption taxes	160	117	23	71	31	200	53	242
Contract liabilities	-	-	-	-	-	57	101	1
Deposits received	9	69	24	12	11	11	13	30
Unearned revenue	-	-	-	-	6	4	3	2
Provision for bonuses	180	200	210	200	222	228	306	277
Provision for loss on orders received	-	51	17	4	1	1	0	0
Current liabilities	2,295	2,974	2,333	1,716	1,287	2,047	2,728	2,969
Long-term borrowings	2,257	978	200	968	1,083	1,037	597	1,312
Long-term unearned revenue	-	-	-	-	-	-	9	923
Provision for retirement benefits	6	-	15	259	273	278	321	326
Other	-	-	-	-	17	15	14	5
Non-current liabilities	2,360	1,059	215	1,228	1,373	1,330	931	2,566
Liabilities	4,655	4,032	2,547	2,944	2,660	3,377	3,659	5,535
Share capital	100	1,952	1,952	1,969	1,983	1,995	1,995	1,995
Legal capital surplus	-	1,852	1,852	1,869	1,883	1,895	1,895	1,895
Other capital surplus	-	-	-	-	-	-	-	11
Capital surplus	-	1,852	1,852	1,869	1,883	1,895	1,895	1,906
Legal retained earnings	25	25	25	25	25	25	25	25
General reserve	3,371	3,771	3,771	3,771	3,771	3,771	3,771	3,771
Retained earnings brought forward	570	1,028	1,791	2,117	2,323	2,772	4,034	5,273
Retained earnings	4,033	4,844	5,587	5,913	6,119	6,568	7,830	9,069
Treasury shares	-	-	-	-0	-0	-0	-78	-68
Shareholders' equity	4,133	8,647	9,391	9,752	9,984	10,459	11,642	12,902
Valuation difference on available-for-sale securities	51	89	64	75	137	116	103	185
Valuation and translation adjustments	51	89	64	75	137	116	103	185
Net assets	4,184	8,737	9,455	9,827	10,121	10,575	11,745	13,087
Liabilities and net assets	8,839	12,769	12,002	12,771	12,781	13,952	15,405	18,622